Pathogenesis to management of hepatocellular carcinoma

by Impact JournalsMolecular pathways and targeted therapeutics in hepatocellular carcinoma. Abbreviations: APC: antigen presenting cell; AXL is a cell surface receptor tyrosine kinase, part of the TAM

Oncology December 22,2023

Pathogenesis to management of hepatocellular carcinoma

by Impact JournalsMolecular pathways and targeted therapeutics in hepatocellular carcinoma. Abbreviations: APC: antigen presenting cell; AXL is a cell surface receptor tyrosine kinase, part of the TAM

Oncology December 22,2023

Finding familiar pathways in kidney cancer

byThomas Jefferson UniversityCredit: CC0 Public Domainp53 is the most famous cancer gene, not least because it's involved in causing over 50% of all cancers. When a cell loses its p53 gene—w

Oncology December 22,2023

Finding familiar pathways in kidney cancer

byThomas Jefferson UniversityCredit: CC0 Public Domainp53 is the most famous cancer gene, not least because it's involved in causing over 50% of all cancers. When a cell loses its p53 gene—w

Oncology December 22,2023

Zebrafish 'avatars' can help decide who should receive radiotherapy treatment

by Liad Hollender, Champalimaud Centre for the UnknownHuman rectal-tumor cells (pink) are tested for radio-sensitivity using a zebrafish avatar. Credit: Bruna Costa & Rita Fior. Champalimaud Centr

Breakthroughs December 22,2023

Zebrafish 'avatars' can help decide who should receive radiotherapy treatment

by Liad Hollender, Champalimaud Centre for the UnknownHuman rectal-tumor cells (pink) are tested for radio-sensitivity using a zebrafish avatar. Credit: Bruna Costa & Rita Fior. Champalimaud Centr

Breakthroughs December 22,2023

Access to high-cost targeted treatments varies for lung cancer

(HealthDay)—Not all patients have access to new, high-cost lung cancer drugs, according to a study recently published in theJournal of the National Cancer Institute.Cathy J. Bradley, Ph.D., from

Oncology December 22,2023

Access to high-cost targeted treatments varies for lung cancer

(HealthDay)—Not all patients have access to new, high-cost lung cancer drugs, according to a study recently published in theJournal of the National Cancer Institute.Cathy J. Bradley, Ph.D., from

Oncology December 22,2023

Researchers identify potential formula for blood cancer vaccine

byThe Mount Sinai HospitalMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0Researchers at the Icahn School of Medicine at

Oncology December 22,2023

Researchers identify potential formula for blood cancer vaccine

byThe Mount Sinai HospitalMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0Researchers at the Icahn School of Medicine at

Oncology December 22,2023

Insurance disparities ID'd in diagnosis of late-stage melanoma

For nonelderly adults in the United States, having Medicaid or no health insurance is associated with increased odds of being diagnosed with late-stage melanoma compared with having private insurance,

Oncology December 22,2023

Insurance disparities ID'd in diagnosis of late-stage melanoma

For nonelderly adults in the United States, having Medicaid or no health insurance is associated with increased odds of being diagnosed with late-stage melanoma compared with having private insurance,

Oncology December 22,2023

Targeted cancer treatment: Innovative approach could prevent serious side effects

byMedical University of ViennaCredit: AI-generated imageTargeted, highly effective cancer treatments often produce debilitating side effects. This is the case with one commonly used therapy whic

Oncology December 22,2023

Targeted cancer treatment: Innovative approach could prevent serious side effects

byMedical University of ViennaCredit: AI-generated imageTargeted, highly effective cancer treatments often produce debilitating side effects. This is the case with one commonly used therapy whic

Oncology December 22,2023

Researchers design new hydrogel for more targeted cancer treatments

by Safa Jinje,University of TorontoGraphical abstract. Credit:Materials Today(2022). DOI: 10.1016/j.mattod.2022.01.023University of Toronto researchers have designed a new way to gro

Oncology December 22,2023

Researchers design new hydrogel for more targeted cancer treatments

by Safa Jinje,University of TorontoGraphical abstract. Credit:Materials Today(2022). DOI: 10.1016/j.mattod.2022.01.023University of Toronto researchers have designed a new way to gro

Oncology December 22,2023

New therapeutic strategy for chemotherapy resistance in ovarian cancer

byThe Wistar InstituteDr. Rugang Zhang. Credit: The Wistar InstituteA study from The Wistar Institute demonstrated that NAMPT, an enzyme critical for NAD+ biosynthesis, mediates selection of ste

Oncology December 22,2023

New therapeutic strategy for chemotherapy resistance in ovarian cancer

byThe Wistar InstituteDr. Rugang Zhang. Credit: The Wistar InstituteA study from The Wistar Institute demonstrated that NAMPT, an enzyme critical for NAD+ biosynthesis, mediates selection of ste

Oncology December 22,2023

Combination of chemo and diabetes drugs shows potential for treating Ewing sarcoma

byHouston MethodistStephen T. Wong, Ph.D., Associate Director, Cores, Biostatistics and BioinformaticsHouston Methodist Cancer Center. Credit: Houston MethodistEwing sarcoma, an aggressive tumor

Oncology December 22,2023

Combination of chemo and diabetes drugs shows potential for treating Ewing sarcoma

byHouston MethodistStephen T. Wong, Ph.D., Associate Director, Cores, Biostatistics and BioinformaticsHouston Methodist Cancer Center. Credit: Houston MethodistEwing sarcoma, an aggressive tumor

Oncology December 22,2023